As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage

OXFORD, England, August 19, 2010 - PharmaVentures, the company behind the PharmaDeals(R) range of business
information, announced today the expansion of its PharmaDeals Agreements
coverage that includes exclusive interviews with deal makers around the
world. The announcement follows major enhancement of its dedicated, market
leading platform delivering deal data and information to the pharmaceutical
and biotechnology sector.

The scope of PharmaDeals Agreements database has been expanded to include
categories of deals that have medical and therapeutic applications in
cosmetics, internet and e-commerce, nutritional supplements, packaging, wound
care, bioterrorism, as well as deeper classifications within drug delivery
technologies.

Fintan Walton, PhD, Chief Executive of PharmaVentures, says, "We are very
excited about our latest version of PharmaDeals. One of the big issues that
face those in researching and analysing deals is the lack of scope within
databases they use which is a result of the huge changes taking place in the
world of deal making. More companies are doing specialist deals, for example,
with orphan drugs, and the world is changing as new technologies, mechanisms
of action and even new therapy areas emerge. Frankly no one else has tried to
come up with solutions to these changes."

New content is also being sourced related to deal making by Clinical
Research and Contract Manufacturing Organizations. The development to the
database augments recent improvements to the classifications and user
interface.

As deal making is a people business subscribers can for the first time
access exclusive television interviews with the key deal makers in the major
pharmaceutical companies as well as key influencers at the corporate level
such as CEOs and Board Members of corporations.

Dr Walton continues, "A key priority for us is to better serve our
customers with information about deals from rapidly developing markets, and
we have done this by considerably increasing our sources, especially in
India, China, and generally within South Asia and South America. These
developments to our content are additional key milestones for us, and, in the
very near future, we shall be bringing news of further offerings to help our
clients' ability to win the best deals for them."

Notes to Editors:

About PharmaVentures

PharmaVentures Limited (www.pharmaventures.com) is based in
Oxford, England and is a leading international corporate advisory firm
supporting its clients' growth ambitions through licensing, joint ventures
and M&A in the healthcare industry. The company works for a variety of
clients from start-ups to global pharmaceutical corporations, their advisors,
investment companies and government bodies. It also produces the highly
popular PharmaDeals(R) range of intelligence products including analysis
tools and reports. In 2006, it launched the world's first dedicated online
pharmaceutical television channel PharmaTelevision(R) (
www.pharmatelevision.com)

www.pharmaventures.com

www.pharmadeals.net

www.pharmatelevision.com

PharmaDeals(R) is a registered Trade Mark of PharmaVentures Ltd.

For further information about PharmaDeals and other PharmaVentures
products and services, including ordering, please contact:

    Doug Cookson
    Commercial Director,
    PharmaVentures
    Magdalen Centre
    Oxford Science Park
    Oxfordshire
    OX4 4GA, UK
    T: +44(0)1865-332731
    E: doug.cookson@pharmaventures.com

Doug Cookson, Commercial Director, PharmaVentures, Magdalen Centre, Oxford Science Park, Oxfordshire, OX4 4GA, UK, T: +44(0)1865-332731, E: doug.cookson at pharmaventures.com